ampelopsin has been researched along with tamarixetin in 1 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (tamarixetin) | Trials (tamarixetin) | Recent Studies (post-2010) (tamarixetin) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 58 | 7 | 42 |
| Protein | Taxonomy | ampelopsin (IC50) | tamarixetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.12 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 1.215 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.02 | |
| Aurora kinase B | Homo sapiens (human) | 7.39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, S; Das, S; Majumder, T; Mukherjee, P; Sarkar, A | 1 |
1 other study(ies) available for ampelopsin and tamarixetin
| Article | Year |
|---|---|
Flavonoids as BACE1 inhibitors: QSAR modelling, screening and in vitro evaluation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Disaccharides; Flavonoids; Flavonols; Humans; Molecular Docking Simulation; Neurons; Oxidative Stress; Plaque, Amyloid; Protein Conformation; Quantitative Structure-Activity Relationship; Quercetin | 2020 |